Trevor Herbert

Natural products: A continuing source of novel drug leads

Introduction to current and future protein therapeutics: A protein engineering perspective

Peptide therapeutics: current status and future directions

A thermostable Cas9 with increased lifetime in human plasma

Design of next-generation protein therapeutics

Synthesis of Heterobifunctional Protein Fusions Using Copper‐Free Click Chemistry and the Aldehyde Tag

Novel fusion of GLP-1 with a domain antibody to serum albumin prolongs protection against myocardial ischemia/reperfusion injury in the rat

Strategies for extended serum half-life of protein therapeutics

Protection of the Furin Cleavage Site in Low-Toxicity Immunotoxins Based on Pseudomonas Exotoxin A

Synthesis of Heterobifunctional Protein Fusions Using Copper‐Free Click Chemistry and the Aldehyde Tag

Nanobodies: Natural Single-Domain Antibodies

Anti-serum albumin domain antibodies in the development of highly potent, efficacious and long-acting interferon